Rosel P, Arranz B, Vallejo J, Oros M, Menchon J, Alvarez P
J Neural Transm (Vienna). 1997; 104(8-9):921-9.
PMID: 9451724
DOI: 10.1007/BF01285560.
Eyal S, Weizman A, Toren P, Dor Y, Mester R, Rehavi M
Psychopharmacology (Berl). 1996; 125(2):141-5.
PMID: 8783388
DOI: 10.1007/BF02249413.
Garvey M, Noel M
J Psychiatry Neurosci. 1995; 20(1):20-4.
PMID: 7865497
PMC: 1188654.
Rehavi M, Ittah Y, Skolnick P, Rice K, Paul S
Naunyn Schmiedebergs Arch Pharmacol. 1982; 320(1):45-9.
PMID: 7121610
DOI: 10.1007/BF00499070.
Plenge P, Mellerup E
Psychopharmacology (Berl). 1982; 77(1):94-7.
PMID: 6812124
DOI: 10.1007/BF00436105.
High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers.
Raisman R, Sechter D, Briley M, Zarifian E, Langer S
Psychopharmacology (Berl). 1981; 75(4):368-71.
PMID: 6803282
DOI: 10.1007/BF00435855.
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteers.
Pimoule C, Briley M, Gay C, Loo H, Sechter D, Zarifian E
Psychopharmacology (Berl). 1983; 79(4):308-12.
PMID: 6407043
DOI: 10.1007/BF00433407.
3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.
Friedl W, Propping P, Weck B
Psychopharmacology (Berl). 1983; 80(1):96-9.
PMID: 6306712
DOI: 10.1007/BF00427505.
Relationship between transmitter uptake inhibition and effects of alpha-adrenoceptor agonists on serotonin and noradrenaline release in the rat brain cortex.
Gothert M, Schlicker E, Kostermann F
Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(2):121-8.
PMID: 6135159
DOI: 10.1007/BF00512384.
Norepinephrine neuronal uptake binding sites in rat brain membranes labeled with [3H]desipramine.
Lee C, Snyder S
Proc Natl Acad Sci U S A. 1981; 78(8):5250-4.
PMID: 6117854
PMC: 320389.
DOI: 10.1073/pnas.78.8.5250.
Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranes.
Barkai A, Kowalik S, Reches A, Cooper T, Fahn S
Psychopharmacology (Berl). 1985; 86(4):400-3.
PMID: 3929309
DOI: 10.1007/BF00427898.
Platelet [3H]imipramine binding in autism and schizophrenia.
Weizman A, Gonen N, Tyano S, Szekely G, Rehavi M
Psychopharmacology (Berl). 1987; 91(1):101-3.
PMID: 3103151
DOI: 10.1007/BF00690935.
The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
Glue P, Cowen P, Nutt D, KOLAKOWSKA T, Grahame-Smith D
Psychopharmacology (Berl). 1986; 90(3):398-402.
PMID: 3097730
DOI: 10.1007/BF00179198.
Glucostatic regulation of (+)-[3H]amphetamine binding in the hypothalamus: correlation with Na+,K+-ATPase activity.
Angel I, Hauger R, Luu M, Giblin B, Skolnick P, Paul S
Proc Natl Acad Sci U S A. 1985; 82(18):6320-4.
PMID: 2994071
PMC: 391045.
DOI: 10.1073/pnas.82.18.6320.
Neuroleptics and beta-carbolines displace (3H)Imipramine from its binding sites in human and rat tissues.
Rommelspacher H, Strauss S
J Neural Transm. 1985; 61(1-2):55-63.
PMID: 2858513
DOI: 10.1007/BF01253051.
Platelet research in psychiatry.
Wirz-Justice A
Experientia. 1988; 44(2):145-52.
PMID: 2831076
DOI: 10.1007/BF01952199.
Effects of N-ethylmaleimide on 5-hydroxytryptamine transport and sodium content in rabbit platelets.
Wolfel R, Halbrugge T, Graefe K
Br J Pharmacol. 1989; 97(4):1308-14.
PMID: 2790384
PMC: 1854639.
DOI: 10.1111/j.1476-5381.1989.tb12593.x.
Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.
Baker G, Greenshaw A
Cell Mol Neurobiol. 1989; 9(1):1-44.
PMID: 2565769
PMC: 11567321.
DOI: 10.1007/BF00711441.
